Trials / Completed
CompletedNCT00457925
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
An Open-label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK221149A, Administered as Single Doses of an Oral Solution and an Intravenous Infusion to Healthy Female Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK221149A |
Timeline
- Start date
- 2006-10-01
- First posted
- 2007-04-09
- Last updated
- 2012-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00457925. Inclusion in this directory is not an endorsement.